Journal
CANCER LETTERS
Volume 523, Issue -, Pages 100-110Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2021.09.038
Keywords
Breast cancer; Drug resistance; microRNAs; Long noncoding RNAs; Mechanisms; TNBC treatment
Categories
Funding
- Natural Science Foundation of Hunan Province [2019JJ20014]
- National Natural Science Foundation of China [81773294]
- Program of National Health and Family Planning Commission of Hunan [20201929]
- Chuanshan Talent Project of the University of South China [CS2018-3-35]
Ask authors/readers for more resources
Triple-negative breast cancer (TNBC) is the most aggressive subtype among breast cancers, with high recurrence partly due to chemoresistance. Studies have shown that noncoding RNAs, especially miRNAs, lncRNAs, and circRNAs, play a role in TNBC resistance, suggesting that targeting ncRNAs may be a promising strategy to overcome chemoresistance.
Triple-negative breast cancer (TNBC) is the most aggressive subtype among breast cancers with high recurrence and this condition is partly due to chemoresistance. Therefore, fully understanding the mechanism of TNBCresistance is the key to overcoming chemoresistance, which will be an effective strategy for TNBC therapy. Various potential mechanisms involved in the chemoresistance of TNBC have been investigated and indicated that noncoding RNAs (ncRNAs) especially microRNAs (miRNAs), long noncoding RNAs (lncRNAs) and circular RNAs (circRNAs) take part in most TNBC resistance. The ncRNA-induced chemoresistance process is involved in the alteration of many activities. here, we mainly summarize the mechanisms of ncRNAs in the chemoresistance of TNBC and discuss the potential clinical application of ncRNAs in the treatment of TNBC, indicating that targeting ncRNAs might be a promising strategy for resensitization to chemotherapies.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available